Assertio Holdings, Inc.

    Assertio Holdings, Inc.

    NNASDAQ:ASRT
    23.50
    USD
    0.00
    (0.00%)
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    141.93
    401.79
    342.07
    446.31
    364.32
    293.23
    194.73
    60.82
    38.57
    49.86
    32.11
    19.67
    18.54
    15.92
    Basic EPS, GAAP
    45.8
    135.62
    -75.59
    -86.85
    -98.08
    34.71
    -184.29
    -16.11
    -0.45
    34.98
    -70.1
    -3.4
    -4.74
    -5.56
    Free Cash Flow per Basic Share
    8.24
    -58.17
    125.41
    66.96
    58.85
    63.01
    75.51
    -37.53
    1.9
    24.99
    10.34
    4.16
    -4.4
    -1.1
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    143.72
    368.79
    310.97
    242.83
    160.42
    205.97
    42.99
    29.33
    34.41
    70.07
    21.87
    19.01
    14.63
    11.73
    Tangible Book Value per Share
    57.41
    295.57
    -684.95
    -630.69
    -590.88
    -441
    -254.11
    -76.38
    -38.19
    8.61
    4.23
    6.38
    7.01
    5.05
    Basic Weighted Avg Shares
    1
    1
    1
    1
    1
    1
    1
    2
    3
    3
    5
    6
    6
    6
    Sales/Revenue/Turnover
    134
    390
    343
    456
    381
    312
    230
    106
    111
    156
    152
    125
    119
    102
    Operating Margin (%)
    6.94
    60.67
    -23.43
    5.38
    -7.6
    20.61
    -0.33
    -44.15
    13
    37.18
    10.55
    -15.03
    -14.51
    -22.27
    Depreciation Expense
    6
    12
    86
    109
    106
    106
    103
    26
    29
    33
    28
    26
    30
    27
    Net Income, GAAP
    43
    132
    -76
    -89
    -102
    37
    -217
    -28
    -1
    110
    -332
    -22
    -30
    -36
    Effective Tax Rate (%)
    - -
    38.17
    - -
    - -
    - -
    2.81
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    32.27
    33.75
    -22.1
    -19.46
    -26.92
    11.84
    -94.64
    -26.48
    -1.15
    70.17
    -218.28
    -17.27
    -25.59
    -34.94
    Working Capital
    180
    560
    89
    79
    -80
    -38
    -81
    -38
    -32
    37
    78
    88
    89
    75
    LT Debt
    - -
    230
    800
    719
    544
    446
    271
    72
    61
    66
    40
    40
    40
    40
    Total Equity
    137
    364
    315
    251
    170
    220
    58
    56
    102
    226
    138
    121
    94
    76
    Return on Invested Capital (%)
    - -
    36.9
    - -
    - -
    - -
    7.89
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    40.06
    - -
    - -
    - -
    13.12
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    39.13
    52.51
    -22.29
    -31.36
    -48.77
    18.93
    -156.1
    -49.61
    -1.62
    66.82
    -182.52
    -16.66
    -28.25
    -38.76

    Capital Structure

    USD

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'26
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    39
    39
    39
    LT Finance Leases
    1
    1
    1
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    6
    6
    6
    Market Capitalization
    8
    58
    12

    Working Capital

    USD

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'26
    Total Current Assets
    264
    217
    167
    Cash, Cash Equivalents & STI
    93
    63
    72
    Accounts Receivable, Net
    141
    120
    62
    Inventories
    25
    24
    23
    Total Current Liabilities
    167
    128
    92
    Payables & Accruals
    158
    120
    85
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    3.06%
    26.27%
    -22.41%
    Free Cash Flow
    74.57%
    186.65%
    -206.72%
    Net Income, GAAP
    -1,008.76%
    -1,841.75%
    40.75%
    Sales/Revenue/Turnover
    -6.2%
    3.94%
    -5%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    32
    31
    29
    32
    125
    2025
    26
    29
    49
    14
    119
    2026
    10
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    -0.71
    -0.58
    -0.46
    -1.65
    -3.4
    2025
    -2.12
    -2.56
    1.78
    -1.86
    -4.74
    2026
    -2.93
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • globenewswire.com

      Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth

    • businesswire.com

      Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its Outstanding 6.50% Convertible Senior Notes due 2027

    • gurufocus.com

      Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?

    • prnewswire.com

      Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?

    • globenewswire.com

      Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders

    • gurufocus.com

      Are SILA, UNF, ASRT, KW Obtaining Fair Deals for their Shareholders?

    • prnewswire.com

      Are SILA, UNF, ASRT, KW Obtaining Fair Deals for their Shareholders?

    • gurufocus.com

      Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT

    • businesswire.com

      Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT

    • gurufocus.com

      Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders

    • prnewswire.com

      Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders

    • gurufocus.com

      Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash

    • businesswire.com

      Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash

    • businesswire.com

      Assertio and Garda Mutually Agree to Delay Launch of Tender Offer

    • businesswire.com

      Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer

    • zacks.com

      Assertio (ASRT) Moves 17.0% Higher: Will This Strength Last?

    • businesswire.com

      Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics

    • zacks.com

      Are Medical Stocks Lagging Assertio (ASRT) This Year?

    • businesswire.com

      Assertio and Garda Mutually Agree to Extend Tender Offer Deadline

    • businesswire.com

      Assertio Provides Update on Garda Therapeutics Tender Process